Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ·Healthcare·Biotechnology
$88.89
+3.35%
Mkt Cap $12.12B
Analyst Ratings
Buy
12
Hold
0
Sell
0
Price Target (29 analysts)
$91.00
Range $46.00 – $110.00
Implied Upside
+2.4%
Consensus $91.00 vs current $88.89